{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06100276",
            "orgStudyIdInfo": {
                "id": "AMT-162-001"
            },
            "organization": {
                "fullName": "UniQure Biopharma B.V.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants With SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",
            "officialTitle": "A Phase 1/2, Multicenter, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants With SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS).",
            "therapeuticArea": [
                "Other"
            ],
            "study": "safety-tolerability-and-exploratory-efficacy-study-of-intrathecally-administered-gene-therapy-amt-in-adult-participants-with-amyotrophic-lateral-sclerosis-als"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-07-30",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-09-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2031-03-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-10-20",
            "studyFirstSubmitQcDate": "2023-10-20",
            "studyFirstPostDateStruct": {
                "date": "2023-10-25",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-19",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-22",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "UniQure Biopharma B.V.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is the study of AMT-162 in Participants with SOD1-ALS and is designed to evaluate the safety, tolerability, and exploratory efficacy of intrathecally administered gene therapy AMT-162. AMT-162-001 is a Phase 1/2, multi-center, single ascending dose study.",
            "detailedDescription": "AMT-162 is an investigational gene therapy that encodes an artificial microribonucleic acid (microRNA or miRNA) targeting the SOD1 gene. This clinical study will test the safety of AMT-162 and explore the hypothesis that it will silence expression of mutant cytosolic SOD1 and thereby ameliorate the course of ALS caused by this mutant gene."
        },
        "conditionsModule": {
            "conditions": [
                "Amyotrophic Lateral Sclerosis"
            ],
            "keywords": [
                "Gene Therapy",
                "AAV (adeno-associated virus)",
                "ALS",
                "SOD1"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 20,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "3 single Ascending Dose Levels",
                    "type": "EXPERIMENTAL",
                    "description": "Experimental: 3 single Ascending Dose Levels\n\nThe study will be open-label with an initial plan to explore 3 dose levels of AMT-162 in approximately 6 to 12 Participants in total. Each Participant will receive a single dose of AMT-162 delivered via an intrathecal (IT) infusion and will be followed for up to 5 years after AMT-162 administration.",
                    "interventionNames": [
                        "Drug: AMT-162"
                    ]
                },
                {
                    "label": "EXPANSION COHORT",
                    "type": "EXPERIMENTAL",
                    "description": "Expansion cohort: To further test selected dose from the SAD part in approximately 6 to 8 participants\n\nThe study will be open-label. Each Participant will receive a single dose of AMT-162 delivered via an intrathecal (IT) infusion and will be followed for up to 5 years after AMT-162 administration.",
                    "interventionNames": [
                        "Drug: AMT-162"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "AMT-162",
                    "description": "AMT-162, the investigational product (IP), is a nonreplicating, rep/cap-deleted, self-complementary Recombinant adeno-associated virus (rAAV) vector based on adeno-associated virus (AAV) serotype rh10 and contains complementary deoxyribonucleic acid (cDNA) encoding an artificial miRNA targeting the SOD1 gene.",
                    "armGroupLabels": [
                        "3 single Ascending Dose Levels",
                        "EXPANSION COHORT"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "To evaluate the safety and tolerability of ascending doses of intrathecally administered AMT-162 in Participants with SOD1-ALS",
                    "description": "Occurrence of TEAEs upon administration of ascending doses of AMT-162",
                    "timeFrame": "up to 5 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Characterization of Immune Response to AMT-162 and Shedding of intrathecally administered AMT-162.",
                    "description": "Any positive results in shedding samples will be summarized at each timepoint. Immunogenicity parameters will be summarized for each visit.",
                    "timeFrame": "up to 5 years"
                },
                {
                    "measure": "Characterization of the Effect of intrathecally administered AMT-162",
                    "description": "Change from Baseline in Slow Vital Capacity (SVC) percent of predict value, Hand-held dynamometry (HHD) scores, and Neurofilament light chain (NfL) protein levels in serum.\n\nImmunogenicity parameters will be summarized for each visit.",
                    "timeFrame": "up to 5 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Confirmed clinical and genetic diagnosis of SOD1-mediated ALS (SOD1-ALS) experiencing signs and/or symptoms of lower motor neuron dysfunction (weakness, atrophy, cramps, fasciculations), with or without upper motor neuron symptoms (weakness, bring reflexes, spasticity).\n2. ALSFRS-R score \u2265 25 at Screening.\n3. Slow vital capacity (SVC) \u226550% of predicted normal value.\n4. Capable of providing informed consent and complying with trial procedures, including: medically able to undergo lumbar puncture and has a responsible caregiver able to attend all clinic visit with the Participant.\n\nExclusion Criteria:\n\n1. SOD1 pathogenic or likely pathogenic variants in amino acid regions 43-47.\n2. Pathogenic repeat expansion in the C9orf72 gene\n3. Any of the following prior or concomitant treatments:\n\n   1. Any prior SOD1 suppression therapy with viral microRNA mediators\n   2. Prior SOD suppression therapy with antisense oligonucleotide (ASO) mediators such as tofersen (QALSODY\u2122). Exception: Patients who previously received tofersen may be enrolled if the last dose of tofersen was received at least 20 weeks prior to the first Screening assessment and if there were no previous tofersen-related SAEs or ongoing tofersen-related adverse events that would increase the risk of receiving AMT-162, per Investigator judgment.\n   3. Other ALS medications riluzole (RILUTEK\u00ae, TIGLUTIK\u00ae), edaravone (RADICAVA\u00ae), and sodium phenylbutyrate and taururosdiol combination (RELYVRIO) or bioequivalents are allowed if dose is stable for 30 days prior to immunosuppression.\n   4. Any prior administration of an AAV gene therapy.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Director Clinical Operations",
                    "role": "CONTACT",
                    "phone": "1-866-520-1257",
                    "email": "medinfo@uniqure.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Executive Director, Clinical Development",
                    "affiliation": "UniQure Biopharma B.V.",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of California Irvine",
                    "city": "Irvine",
                    "state": "California",
                    "zip": "92697",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Namita Goyal, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.66946,
                        "lon": -117.82311
                    }
                },
                {
                    "facility": "California Pacific Medical Center",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94109",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Daniela Sanchez",
                            "role": "CONTACT",
                            "phone": "415-600-1764",
                            "email": "daniela.sanchez@sutterhealth.org"
                        },
                        {
                            "name": "Mackenzie Kenneally",
                            "role": "CONTACT",
                            "phone": "415-600-0484",
                            "email": "mackenzie.kenneally@sutterhealth.org"
                        },
                        {
                            "name": "Jonathan S Katz, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Liberty Jenkins, MD",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                },
                {
                    "facility": "Northwestern University Feinberg School of Medicine",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60611",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "Massachusetts General Hospital, Sean M. Healey and AMG Center for ALS Research",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Alison Wheeler",
                            "role": "CONTACT",
                            "phone": "617-643-8449",
                            "email": "AWHEELER7@mgh.harvard.edu"
                        },
                        {
                            "name": "Mark Garret, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Columbia University Irving Medical Center",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10032",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Helen Mej\u00eda Santana, MA",
                            "role": "CONTACT",
                            "phone": "212-305-9183",
                            "email": "hm28@cumc.columbia.edu"
                        },
                        {
                            "name": "Matthew Harms, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "University of Pennsylvania School of Medicine",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Stephanie Hansen, MD",
                            "role": "CONTACT",
                            "phone": "267-438-7518",
                            "email": "stephanie.hansen@pennmedicine.upenn.edu"
                        },
                        {
                            "name": "Abigail Browngoehl",
                            "role": "CONTACT",
                            "phone": "267-343-6395",
                            "email": "abigail.browngoehl@pennmedicine.upenn.edu"
                        },
                        {
                            "name": "Colin Quinn, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000016472",
                    "term": "Motor Neuron Disease"
                },
                {
                    "id": "D000000690",
                    "term": "Amyotrophic Lateral Sclerosis"
                },
                {
                    "id": "D000012598",
                    "term": "Sclerosis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000019636",
                    "term": "Neurodegenerative Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000009468",
                    "term": "Neuromuscular Diseases"
                },
                {
                    "id": "D000013118",
                    "term": "Spinal Cord Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000057177",
                    "term": "TDP-43 Proteinopathies"
                },
                {
                    "id": "D000057165",
                    "term": "Proteostasis Deficiencies"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M18879",
                    "name": "Motor Neuron Disease",
                    "asFound": "Lateral Sclerosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4024",
                    "name": "Amyotrophic Lateral Sclerosis",
                    "asFound": "Amyotrophic Lateral Sclerosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15415",
                    "name": "Sclerosis",
                    "asFound": "Sclerosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17522",
                    "name": "Virus Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M21558",
                    "name": "Neurodegenerative Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12411",
                    "name": "Neuromuscular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15915",
                    "name": "Spinal Cord Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M28759",
                    "name": "TDP-43 Proteinopathies",
                    "relevance": "LOW"
                },
                {
                    "id": "M28747",
                    "name": "Proteostasis Deficiencies",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T349",
                    "name": "Amyotrophic Lateral Sclerosis",
                    "asFound": "Amyotrophic Lateral Sclerosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4699",
                    "name": "Primary Lateral Sclerosis",
                    "asFound": "Lateral Sclerosis",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}